Intended for healthcare professionals

Rapid response to:

Research News

Risk of breast cancer recurrence remains for years after endocrine treatment ends, study finds

BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5167 (Published 08 November 2017) Cite this as: BMJ 2017;359:j5167

Rapid Response:

Breast Cancer - Pill

It goes without saying that the question of aetiology in breast cancer is a major health issue. However the pitch has been seriously queered by conflicting data.1 The propensity for bias is enormous. There are many vested interests that want to insure the innocence of the pill and exogenous female hormones in general. These include the pharma industry who make money from it; those who support fertility control at any cost; those who support the myth of population explosion; those who consider reducing childbirths to be a positive contribution to climate change; people in general who have come to rely on the pill as a necessary part of modern living.

The odds are stacked against any data showing the pill greatly increases the incidence of breast cancer. Such data exists and I have cited relevant authors in the monograph mentioned in the competing interests statement. We all know that bias is a formidable obstacle to truth, especially a fragile unwanted truth.

Breen EG. The Screech Owls of Breast Cancer. Author House 2013.

Competing interests: Author of "Screech Owls of Breast Cancer."

10 November 2017
eugene G breen
psychiatrist
62/62 Eccles St Dublin 7